Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Healthy Volunteers: f
View:

• Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria.

• affiliation to the French Health Care System Sécurité sociale

Locations
Other Locations
France
Hôpital Pitié-Salpêtrière
RECRUITING
Paris
Contact Information
Primary
Mathieu Kerneis, MD
mathieu.kerneis@aphp.fr
+33142163001
Time Frame
Start Date: 2022-01-23
Estimated Completion Date: 2041-05-01
Participants
Target number of participants: 1400
Treatments
Acute myocarditis
Patients hospitalized for an acute myocarditis.
Related Therapeutic Areas
Sponsors
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov